journal
https://read.qxmd.com/read/36899123/disruption-of-mitochondrial-oxidative-phosphorylation-by-chidamide-eradicates-leukemic-cells-in-aml
#1
JOURNAL ARTICLE
Jun-Dan Wang, Jue-Qiong Xu, Zi-Jie Long, Jian-Yu Weng
PURPOSE: Nowadays, the oxidative phosphorylation (OXPHOS) correlated with leukemogenesis and treatment response is extensive. Thus, exploration of novel approaches in disrupting OXPHOS in AML is urgently needed. MATERIALS AND METHODS: Bioinformatical analysis of TCGA AML dataset was performed to identify the molecular signaling of OXPHOS. The OXPHOS level was measured through a Seahorse XFe96 cell metabolic analyzer. Flow cytometry was applied to measure mitochondrial status...
March 10, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36897508/brain-metastasis-in-breast-cancer-focus-on-genes-and-signaling-pathways-involved-blood-brain-barrier-and-treatment-strategies
#2
REVIEW
Yogita Chhichholiya, Malayil Ruthuparna, Harini Velagaleti, Anjana Munshi
Breast cancer (BC) is one of the most prevalent types of cancer in women. Despite advancement in early detection and efficient treatment, recurrence and metastasis continue to pose a significant risk to the life of BC patients. Brain metastasis (BM) reported in 17-20 percent of BC patients is considered as a major cause of mortality and morbidity in these patients. BM includes various steps from primary breast tumor to secondary tumor formation. Various steps involved are primary tumor formation, angiogenesis, invasion, extravasation, and brain colonization...
March 10, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36862282/jhdm1d-as1-driven-inhibition-of-mir-940-releases-artn-expression-to-induce-breast-carcinogenesis
#3
JOURNAL ARTICLE
Yonggang Zuo, Mingde Ma, Yuqing Wen, Liang Chang, Changping Qu
INTRODUCTION: As ceRNA network of long non-coding RNA (lncRNA)-microRNA (miR)-messenger RNAs (mRNA) can be predicted on the basis of bioinformatics tools, we are now one step closer to deeper understanding carcinogenic mechanisms. In this study, we clarified the mechanistic understanding of JHDM1D-AS1-miR-940-ARTN ceRNA network in the development of breast cancer (BC). MATERIALS AND METHODS: The lncRNA-miRNA-mRNA interaction of interest was predicted by in silico analysis and identified by conducting RNA immunoprecipitation, RNA pull-down and luciferase assays...
March 2, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36856921/pd-l1-pd-1-blockage-enhanced-the-cytotoxicity-of-natural-killer-cell-on-the-non-small-cell-lung-cancer-nsclc-by-granzyme-b-secretion
#4
JOURNAL ARTICLE
Duan-Rui Qiao, Jun-Ya Cheng, Wei-Qun Yan, Hai-Jun Li
OBJECTIVE: To explore the role of PD-L1/PD-1 blockage in the cytotoxicity of natural killer cell in NSCLC. METHODS: Two NSCLC cell lines, Calu-1 and H460, were tested for susceptibility to the cytolytic activity of freshly isolated healthy donor NK cells by a non-radioactive cellular cytotoxicity assay kit. Western blot analysis, FACS, ELISA and antibody blockage experiments were conducted to determine the mechanisms. NK cells isolated from NSCLC patients were also collected for functional assays...
March 1, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36856920/purinergic-p2x7r-as-a-potential-target-for-pancreatic-cancer
#5
REVIEW
Qingqing Yu, Xin Wang, Xinyu Li, Xue Bai, Ronglan Zhao, Xiaoxiang Peng
Pancreatic cancer is one of the deadliest types of cancer, with a death rate nearly equal to the incidence. The P2X7 receptor (P2X7R) is a kind of extracellular adenosine triphosphate (ATP)-gated ion channel with special permeability, which exists in most tissues of human body and mediates inflammation-related signaling pathways and immune signal transduction after activation. P2X7R is also present on the surface of several tumor cells and is involved in tumor growth and progression. P2X7R expression in pancreatic cancer has also been identified in recent studies...
March 1, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36853400/potential-roles-of-lncrna-xist-mirnas-mrnas-in-human-cancer-cells
#6
REVIEW
Maryam Farzaneh, Ava Nasrolahi, Farhoodeh Ghaedrahmati, Tariq Masoodi, Sajad Najafi, Mohadeseh Sheykhi-Sabzehpoush, Mahrokh Abouali Gale Dari, Klaudia Radoszkiewicz, Shahab Uddin, Shirin Azizidoost, Seyed Esmaeil Khoshnam
Long non-coding RNAs (lncRNAs) are non-coding RNAs that contain more than 200 nucleotides but do not code for proteins. In tumorigenesis, lncRNAs can have both oncogenic and tumor-suppressive properties. X inactive-specific transcript (XIST) is a known lncRNA that has been implicated in X chromosome silencing in female cells. Dysregulation of XIST is associated with an increased risk of various cancers. Therefore, XIST can be a beneficial prognostic biomarker for human malignancies. In this review, we attempt to summarize the emerging roles of XIST in human cancers...
February 28, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36853399/chimeric-antigen-receptor-t-cells-therapy-in-solid-tumors
#7
REVIEW
Fatimah Rababah, Taqwa Alabduh, AlHareth Awawdeh, Tareq Shatnawi, Maha Al-Shdaifat, Elana Ibdah, Shatha Shatnawi, Yahia AbuZetun, Ahmed Mohamed Helaly, Doaa S Ghorab
Chimeric antigen receptor T cells therapy (CAR-T therapy) is a class of ACT therapy. Chimeric antigen receptor (CAR) is an engineered synthetic receptor of CAR-T, which give T cells the ability to recognize tumor antigens in a human leukocyte antigen-independent (HLA-independent) manner and enables them to recognize more extensive target antigens than natural T cell surface receptor (TCR), resulting in tumor destruction. CAR-T is composed of an extracellular single-chain variable fragment (scFv) of antibody, which serves as the targeting moiety, hinge region, transmembrane spacer, and intracellular signaling domain(s)...
February 28, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36848028/the-synergistic-anticancer-effect-of-cbd-and%C3%A2-dox-in%C3%A2-osteosarcoma
#8
JOURNAL ARTICLE
Juncheng Li, Wei Jiang, Wenhao Shan, Aiying Luo, Gaoyang Qu, Jiongfeng Zhang, Xiaohui Luo, Jian Xia
BACKGROUND: Osteosarcoma is a malignant tumor that can present with pain in the bones, joints, and local masses. The incidence is highest in adolescents, and the most common sites are the distal femur, proximal tibia and proximal humerus metaphyseal. Doxorubicin is the first-line chemotherapeutic agent for the treatment of osteosarcoma, but it has many side effects. Cannabidiol is a non-psychoactive plant cannabinoid cannabinol (CBD) that has been shown to be effective against osteosarcoma; however, the molecular targets and mechanisms of CBD action in osteosarcoma remain unclear...
February 27, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36826709/characterization-of-cuproptosis-identified-immune-microenvironment-and-prognosis-in-acute-myeloid-leukemia
#9
JOURNAL ARTICLE
Dongmei Luo, Songyang Liu, Jie Luo, Hong Chen, Zherou He, Zicheng Gao, Ziyu Wen, Xiaoli Liu, Na Xu
BACKGROUND: Recent studies have reported that cuproptosis, a novel cell death pathway, strongly correlates with mitochondrial metabolism. In addition, the studies reported that cuproptosis plays a role in the development of several cancers and is regulated by protein lipoylation. During cuproptosis, copper binds to the lipoylated proteins and mediates cancer progression. However, the role of cuproptosis in acute myeloid leukemia (AML) patients is yet to be explored. METHODS: This study curated seven cuproptosis-related-genes (CRGs): FDX1, DLAT, PDHB, PDHA1, DLD, LIAS, and LIPT1 to determine cuproptosis modification patterns and the CRGs signature in AML...
February 24, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36820954/alkbh5-decreases-slc7a11-expression-by-erasing-m6a-modification-and-promotes-the-ferroptosis-of-colorectal-cancer-cells
#10
JOURNAL ARTICLE
Jing Luo, Hongmei Yu, Zhen Yuan, Tao Ye, Bo Hu
BACKGROUND: Colorectal cancer (CRC) is the major subtype of gastrointestinal malignancy and involves cancer-related genes and signaling pathways to regulate ferroptosis. The present study was conducted to analyze the role of alkB homolog 5 (ALKBH5) in the ferroptosis of CRC cells and provide novel targets for CRC treatment. METHODS: The transcriptional and protein levels of ALKBH5 and solute carrier family 7 members 11 (SLC7A11) in tissues and cells were determined by qRT-PCR and Western blot assay...
February 23, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36820953/eno1-promotes-immunosuppression-and-tumor-growth-in-pancreatic-cancer
#11
JOURNAL ARTICLE
Chen Kai Huang, Lei Lv, Huanliang Chen, Ying Sun, Yong Ping
BACKGROUND: Pancreatic adenocarcinoma (PAAD) is a highly aggressive and malignant cancer type with the highest mortality rate of all major cancers. However, the molecular and tumor immune escape mechanism underlying pancreatic cancer remains largely unclear. α-enolase (ENO1) is a glycolytic enzyme reported to overexpress in a variety of cancer types. This study was undertaken to investigate the functional role and therapeutic potential of ENO1 in pancreatic cancer. METHODS: We examined the expression levels of ENO1 across a broad spectrum of cancer types from the TCGA database...
February 23, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36808598/clinical-characteristics-and-outcomes-of-follicular-lymphoma-patients-with-extranodal-involvement-analysis-of-a-series-of-1090-cases-in-china
#12
JOURNAL ARTICLE
Zhijuan Lin, Jie Zha, Shuhua Yi, Zhifeng Li, Lingyan Ping, Xiaohua He, Liyuan Fan, Haifeng Yu, Zhong Zheng, Wei Xu, Feili Chen, Ying Xie, Biyun Chen, Huilai Zhang, Li Wang, Kaiyang Ding, Wenyu Li, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
BACKGROUND: Follicular lymphoma (FL) is the most common indolent B cell lymphoma in the world. The clinical features of extranodal involvement in FL were never extensively described. METHODS: We enrolled 1090 patients diagnosed as newly diagnosed FL at ten medical institutions in China from 2000 to 2020 and conducted this analysis and retrospectively explored clinical characteristics and outcomes of FL patients with extranodal involvement. RESULTS: 400 (36...
February 19, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36807057/nanoparticles-for-cancer-therapy-a-review-of-influencing-factors-and-evaluation-methods-for-biosafety
#13
REVIEW
Jinghua Li, Tao Wu, Shiman Li, Xinyan Chen, Zhiming Deng, Yong Huang
Nanoparticles are widely used in the biomedical field for diagnostic and therapeutic purposes due to their small size, high carrier capacity, and ease of modification, which enable selective targeting and as contrast agents. Over the past decades, more and more nanoparticles have received regulatory approval to enter the clinic, more nanoparticles have shown potential for clinical translation, and humans have increasing access to them. However, nanoparticles have a high potential to cause unpredictable adverse effects on human organs, tissues, and cells due to their unique physicochemical properties and interactions with DNA, lipids, cells, tissues, proteins, and biological fluids...
February 19, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36802014/correction-to-metabolic-response-after-68%C3%A2-ga%C3%A2-psma%C3%A2-pet-ct%C3%A2-directed-igrt-sbrt-for-oligometastases-prostate-cancer
#14
Ahmed Gawish, Nurlan Abdullayev, Souhir El-Arayedh, Burkard Röllich, Hans-Joachim Ochel, Thomas B Brunner
No abstract text is available yet for this article.
February 18, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36802013/sex-differences-in-the-diagnosis-treatment-and-prognosis-of-cancer-the-rationale-for-an-individualised-approach
#15
JOURNAL ARTICLE
Ruth Vera, Oscar Juan-Vidal, María José Safont-Aguilera, Francisco Ayala de la Peña, Aránzazu González Del Alba
BACKGROUND: Precision medicine in oncology aims to identify the most beneficial interventions based on a patient's individual features and disease. However, disparities exist when providing cancer care to patients based on an individual's sex. OBJECTIVE: To discuss how sex differences impact the epidemiology, pathophysiology, clinical manifestations, disease progression, and response to treatment, with a focus on data from Spain. RESULTS: Genetic and environmental factors (social or economic inequalities, power imbalances, and discrimination) that contribute to these differences adversely affect cancer patient health outcomes...
February 18, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36808392/mesenchymal-stem-cells-derived-secretome-and-extracellular-vesicles-perspective-and-challenges-in-cancer-therapy-and-clinical-applications
#16
REVIEW
Jack Gemayel, Diana Chaker, Georges El Hachem, Melissa Mhanna, Rawad Salemeh, Colette Hanna, Frederic Harb, Ahmad Ibrahim, Alain Chebly, Charbel Khalil
Stem cell-based therapies have been foreshowed as a promising therapeutic approach for the treatment of several diseases. However, in the cancer context, results obtained from clinical studies were found to be quite limited. Deeply implicated in inflammatory cues, Mesenchymal, Neural, and Embryonic Stem Cells have mainly been used in clinical trials as a vehicle to deliver and stimulate signals in tumors niche. Although these stem cells have shown some therapeutical promises, they still face several challenges, including their isolation, immunosuppression potential, and tumorigenicity...
February 17, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36795259/ezrin-regulates-the-progression-of-nsclc-by-yap-and-pd-l1
#17
JOURNAL ARTICLE
Fan Bu, Yeping Zhang, Ning Zhao, Xiaoai Tian, Yirong Xu
PURPOSE: To determine whether ezrin regulates Yes-associated protein (YAP) and programed cell death ligand-1 (PD-L1), which are involved in the invasion and metastasis of non-small cell lung cancer (NSCLC). METHODS: Immunohistochemistry of 164 NSCLC and 16 para-cancer tissues was performed to detect ezrin, YAP, and PD-L1 expression. Further, H1299 and A549 cells were transfected with lentivirus, and then colony formation, CCK8, transwell, and wound-healing assays were used to assess cell proliferation, migration, and invasion...
February 16, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36792847/glycolysis-regulator-pfkp-induces-human-melanoma-cell-proliferation-and-tumor-growth
#18
JOURNAL ARTICLE
Cheng Chen, Xuejun Zhang
PURPOSE: Cutaneous melanoma is an aggressive and deadly cancer resulting from malignant transformation of cells involved in skin pigmentation. Glycolysis is widely implicated in cancer progression, but its precise role in melanoma has not been extensively studied. Here, we investigated the role of the glycolysis regulator phosphofructokinase 1 platelet isoform (PFKP) in melanoma progression. METHODS: PFKP expression in human melanoma tissues was analyzed by immunohistochemistry...
February 16, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36790676/the-prognostic-value-of-daam2-in-lower-grade-glioma-liver-cancer-and-breast-cancer
#19
JOURNAL ARTICLE
Zeying Li, Xiao Wei, Yichao Zhu
PURPOSE: Dishevelled-associated activator of morphogenesis 2 (DAAM2) is a formin protein and has a potential role in the tumor metastasis. The prognostic value of DAAM2 in pan-cancer is investigated in this study. METHODS: TCGA and GTEx database were downloaded to perform bioinformatics analysis and ROC curves. Then we explored protein-protein interaction and GO-KEGG enrichment to figure out the protein pathways associated with DAAM2 and studied DAAM2-related immune infiltration and methylation...
February 15, 2023: Clinical & Translational Oncology
https://read.qxmd.com/read/36790675/progress-of-gut-microbiome-and-its-metabolomics-in-early-screening-of-colorectal-cancer
#20
REVIEW
Lujia Zhou, Zhengting Jiang, Zhilin Zhang, Juan Xing, Daorong Wang, Dong Tang
Gut microbes are widely considered to be closely associated with colorectal cancer (CRC) development. The microbiota is regarded as a potential identifier of CRC, as several studies have found great significant changes in CRC patients' microbiota and metabolic groups. Changes in microbiota, like Fusobacterium nucleatum and Bacteroides fragilis, also alter the metabolic activity of the host, promoting CRC development. In contrast, the metabolome is an intuitive discriminative biomarker as a small molecular bridge to distinguish CRC from healthy individuals due to the direct action of microbes on the host...
February 15, 2023: Clinical & Translational Oncology
journal
journal
41053
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.